Furthermore, SNHG12 may serve as a promotor in multiple cancer-related pathways, such as Slug/zinc finger E-box-binding homeobox 2 (ZEB2) pathway, Notch2/Notch pathway, phosphatidylinositol 3-kinase (PI3K)/AKT pathway, and Wnt/β‐catenin signaling pathway [29–32]. The gene discussed is AKT1; the disease is cancer.